專(zhuān)家介紹
劉相燕
社會(huì)兼職
中國(guó)抗癌協(xié)會(huì)腫瘤微創(chuàng)治療專(zhuān)業(yè)委員會(huì)肺癌微創(chuàng)治療分會(huì)委員(國(guó)家級(jí)),山東省醫(yī)學(xué)會(huì)胸外科分會(huì)委員,山東省醫(yī)學(xué)會(huì)食管外科專(zhuān)業(yè)組副組長(zhǎng),山東省抗癌協(xié)會(huì)胸部腫瘤專(zhuān)業(yè)委員會(huì)委員等。
優(yōu)勢(shì)擅長(zhǎng)
更多發(fā)表論文
1. CCL21-CCR7 promotes the lymph node metastasis of esophageal squamous cell carcinoma by up-regulating MUC1. J Exp Clin Cancer Res. 2015 Dec 15; 34. 通訊作者
2. The upregulation of miRNA-146a inhibited biological behaviors of ESCC through inhibition of IRS2. Tumour Biol. 2016 Apr;37(4).通訊作者
3. PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma. Tumour Biol. 2015 Aug;36(8).通訊作者
4. Activated STAT3 correlates with prognosis of non-small cell lung cancer and indicates new anticancer strategies. Cancer Chemother Pharmacol. 2015 May;75(5).通訊作者
5. Therapeutic efficacy evaluation of postoperative adjuvant radiotherapy in mid-thoracic esophageal carcinoma patients underwent Ivor Lewis esophagectomy with two-field lymphadenectomy. Med Oncol. 2015 Feb;32(2).通訊作者
6. Inactivation of RUNX3 predicts poor prognosis in esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy. Med Oncol. 2014 Dec;31(12).通訊作者
7. The relationship between activated K-ras and HLA class I antigen downregulation in metastasis of non-small cell lung cancer. J Int Med Res. 2013;41(5). 通訊作者
8. CCR7: A Metastasis and Prognosis Indicator of Postoperative Patients with Esophageal Carcinoma. Hepatogastroenterology. 2013 ;60(124).第一作者
詳細(xì)>>相關(guān)文章
- 具有影響力論著
- 臨床營(yíng)養(yǎng)線(xiàn)上MDT系列學(xué)術(shù)活動(dòng)第二期成功舉辦
- 胸腔內(nèi)巨大腫瘤重達(dá)8斤!省醫(yī)胸外科完成一例巨大胸腔腫瘤切除手術(shù)
- 山東省立醫(yī)院(集團(tuán))利津中心醫(yī)院簽約揭牌儀式暨義診活動(dòng)成功舉辦
- 山東省立醫(yī)院胸外科副主任——?jiǎng)⑾嘌?/font>
- 我院科研成果“肺癌縱隔淋巴結(jié)隱匿性微轉(zhuǎn)移機(jī)制的研究”通過(guò)鑒定—達(dá)到國(guó)際先進(jìn)水平
- 中國(guó)抗癌協(xié)會(huì)腫瘤微創(chuàng)治療專(zhuān)業(yè)委員會(huì)肺癌微創(chuàng)綜合治療分會(huì)成立大會(huì)暨第一屆中國(guó)肺癌微創(chuàng)綜合治療學(xué)術(shù)交流會(huì)在濟(jì)南召開(kāi)
更多
相關(guān)文章